Swedish Neuroscience Institute was awarded a 7-year, $2.2M grant by the National Institute of Neurological Disease and Stroke (NINDS) to participate in the NeuroNEXT program, a national consortium of 25 neuroscience centers of excellence that will conduct early-stage clinical trials. John W. Henson, MD, FAAN, and Daniel S. Rizzuto, PhD, will lead the effort at Swedish. Swedish Neuroscience Institute was the only non-university hospital chosen to participate, highlighting the value of Swedish’s investments in research and clinical infrastructure. For more information about NeuroNEXT click here
The Seattle Brain Cancer Walk is happening this Saturday the 24th of September starting at the Seattle Center’s Founders Court, where thousands of people will join together and walk for a great cause.
The Seattle Brain Cancer Walk is a national event to raise awareness about brain cancer and fund brain cancer research and comprehensive care for patients and families in the Pacific Northwest. In particular, affected families come together to honor the memory of a loved one lost to brain cancer or a member in their family living with this disease.
Here is a heartfelt article of just that, an Auburn man walks in memory of his wife. To read the entire article, click here.
David Newell, M.D., neurosurgeon and co-executive director of the Swedish Neuroscience Institute (SNI), co-authored the cover article in the September Journal of Neurosurgery on the results of a study using ultrasound for the treatment of brain hemorrhage. The study involved 33 patients with spontaneous intracerebral hemorrhage who were screened for inclusion in a SNI clinical study known as “SLEUTH” (Safety of Lysis with Ultrasound in the Treatment of Intracerebral and Intraventricular Hemorrhage). Read the abstract and full text of the article. Read background information on the study. Watch a related video on WebMD.
The Spring 2011 edition of BrainWaves is now available online.
BrainWaves is the newsletter of the Swedish Neuroscience Institute. Published quarterly, BrainWaves provides information about neurological conditions treated at the Institute, and also profiles the programs, services, and new initiatives of the institute and its staff.
Also check out our past editions of the BrainWaves newsletter.
Each spring, The Merrill P. Spencer, M.D. Endowed Lecture is presented in conjunction with the annual Swedish Neuroscience Institute Cerebrovascular Symposium. This year, we are pleased to welcome Dr. Hugh Markus, Professor of Neurology at St. George’s University of London.
Hugh Markus was educated in Medicine at Cambridge and Oxford Universities and then carried out medical jobs in Oxford, London and Nottingham before training in neurology in London. He was senior lecturer and subsequently, reader in neurology at Kings College London before moving to the chair of neurology at St George’s in 2000.
His clinical interests are in stroke, and he is clinical lead for stroke at St George’s Hospital. He is involved in both acute stroke care and outpatient stroke clinics, and runs specialist services for patients with sub cortical vascular disease and genetic forms of stroke.
Course Chair: Rod J. Oskouian, Jr., M.D, Neurosurgery, Spine Surgery, Swedish Neuroscience Institute.
Today, health-care providers who treat patients with spinal tumors are able to offer a myriad of treatment options that were essentially non-existent in the recent past. Internationally renowned speaker, inventor, entrepreneur and neurosurgeon, John R. Alder, M.D., will present the keynote presentation at this year's symposium and initiate our discussion of the technical and therapeutic options available for spinal tumor patients.
For full course information and to register: http//www.swedish.org/spinaltumors2011
The Tuberous Sclerosis Alliance announced today that it has designated the Swedish Pediatric Neuroscience Center (SPNC) at SNI as a TSC Clinic. Marcio Sotero, MD, medical director of SPNC, is the director of the new center. This designation is an important step forward in the regional delivery of care to patients with tuberous sclerosis, as the TSC Clinics closest to Seattle are located at the Barrow Neurological Institute in Phoenix and Children’s Hospital in Oakland, CA.
TSC is a genetic disorder that causes tumors to form in many different organs, primarily in the brain, eyes, heart, kidney, skin and lungs. Seizures are a very common manifestation, and some people with TSC experience developmental delay, mental retardation and autism.